Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Killed in Crash at Highway 58 and Tehachapi Boulevard


Man Hit by Car in Fatal Tehachapi Accident

Tehachapi, CA (May 19, 2020) – A man was killed in a pedestrian crash in Tehachapi. The fatal accident occurred on the evening of May 19 at Highway 58 and Tehachapi Boulevard.

A car was heading west on East Tehachapi Boulevard while a man was walking northbound. The driver failed to yield to a red light at the intersection and hit the man while he was in a marked crosswalk.

Paramedics arrived and found the man lying on the ground. He was taken to a local hospital, where he later died. The driver remained at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim. 

#Tehachapi

#93561


May 21, 2020

1 Killed in Crash at Mt. Vernon Avenue and Niles Street

3 Vehicles Involved in Fatal Bakersfield Accident...


November 13, 2019

Woman Killed in Crash on Main Street

3 Vehicles Involved in Fatal Riverside Accident...


December 5, 2019

1 Killed, 1 Injured in Head-on Crash on D Street

2 Vehicles Involved in Fatal Victorville Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.